Grafični prikazi informacij

informativno gradivo

Healthcare-associated infections – a threat to patient safety in Europe

A total of 8.9 million HAIs were estimated to occur each year in European hospitals and long-term care facilities

Antimicrobial use in: Long-term care facilities

3/4 of the prophylaxis courses in long-term care facilities were given to prevent urinary tract infections. This practice is associated with increased antimicrobial resistance.

Antimicrobial use in European hospitals and long-term care facilities

1 in 3 patients received at least one antimicrobial on any given day. Some of this use may be unnecessary and contribute to the spread of antimicrobial resistance.

Antibiotic resistance – an increasing threat to human health

Each year, 33000 people die from an infection due to bacteria resistant to antibiotics. The burden is comparable to that of inﬂuenza, tuberculosis and HIV/AIDS combined.

We work together to fight antibiotic resistance keeping Europeans healthy

How do EU agencies contribute to the fight against antimicrobial resistance? See a joint EMA/ECDC/EFSA/EEA infographic

Antibiotiki: bodite odgovorni

V njej je pojasnjeno, kaj je odpornost proti antibiotikom, in poudarjen obseg težav, s katerimi se spopadamo zaradi odpornosti proti antibiotikom in uporabe antibiotikov pri ljudeh – v bolnišnicah in skupnosti.

Kako se širi odpornost proti antibiotikom?

Ta grafični prikaz pojasnjuje, kako se odpornost proti antibiotikom širi v živinoreji, skupnosti, zdravstvenih ustanovah in s potovanji.

Odpornost proti mikrobom v Evropi leta 2014

Pregled podatkov o odpornost proti mikrobom v Evropi, objavljenih leta 2014

Naraščajoča odpornost proti rezervnim antibiotikom leta 2013

Karbapenemi so glavna vrsta rezervnih antibiotikov za zdravljenje bakterijskih okužb. Širjenje okužb, odpornih proti karbapenemom, ogroža zdravstveno varstvo in varnost bolnikov v Evropi, saj resno zmanjšuje možnost zdravljenja okužb.